Association Between a Chloride-Liberal vs Chloride-Restrictive Intravenous Fluid Administration Strategy and Kidney Injury in Critically Ill Adults

被引:841
作者
Yunos, Nor'azim Mohd
Bellomo, Rinaldo [1 ,5 ]
Hegarty, Colin [2 ]
Story, David [3 ]
Ho, Lisa [4 ]
Bailey, Michael [5 ]
机构
[1] Austin Hosp, Dept Intens Care, Melbourne, Vic 3084, Australia
[2] Austin Hosp, Dept Lab Med, Melbourne, Vic 3084, Australia
[3] Austin Hosp, Dept Anaesthesia, Melbourne, Vic 3084, Australia
[4] Austin Hosp, Dept Pharm, Melbourne, Vic 3084, Australia
[5] Monash Univ, Dept Epidemiol & Prevent Med, Australia & New Zealand Intens Care Res Ctr, Melbourne, Vic 3004, Australia
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2012年 / 308卷 / 15期
关键词
INTERNATIONAL CONSENSUS CONFERENCE; RENAL-REPLACEMENT THERAPY; HYPERONCOTIC COLLOIDS; SALINE RESUSCITATION; 0.9-PERCENT SALINE; CODE RATES; BLOOD-FLOW; ACID-BASE; MORTALITY; ALBUMIN;
D O I
10.1001/jama.2012.13356
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Administration of traditional chloride-liberal intravenous fluids may precipitate acute kidney injury (AKI). Objective To assess the association of a chloride-restrictive (vs chloride-liberal) intravenous fluid strategy with AKI in critically ill patients. Design, Setting, and Patients Prospective, open-label, sequential period pilot study of 760 patients admitted consecutively to the intensive care unit (ICU) during the control period (February 18 to August 17, 2008) compared with 773 patients admitted consecutively during the intervention period (February 18 to August 17, 2009) at a university-affiliated hospital in Melbourne, Australia. Interventions During the control period, patients received standard intravenous fluids. After a 6-month phase-out period (August 18, 2008, to February 17, 2009), any use of chloride-rich intravenous fluids (0.9% saline, 4% succinylated gelatin solution, or 4% albumin solution) was restricted to attending specialist approval only during the intervention period; patients instead received a lactated solution (Hartmann solution), a balanced solution (Plasma-Lyte 148), and chloride-poor 20% albumin. Main Outcome Measures The primary outcomes included increase from baseline to peak creatinine level in the ICU and incidence of AKI according to the risk, injury, failure, loss, end-stage (RIFLE) classification. Secondary post hoc analysis outcomes included the need for renal replacement therapy (RRT), length of stay in ICU and hospital, and survival. Results Chloride administration decreased by 144 504 mmol (from 694 to 496 mmol/patient) from the control period to the intervention period. Comparing the control period with the intervention period, the mean serum creatinine level increase while in the ICU was 22.6 mu mol/L (95% CI, 17.5-27.7 mu mol/L) vs 14.8 mu mol/L (95% CI, 9.8-19.9 mu mol/L) (P=.03), the incidence of injury and failure class of RIFLE-defined AKI was 14%(95% CI, 11%-16%; n=105) vs 8.4% (95% CI, 6.4%-10%; n=65) (P<.001), and the use of RRT was 10% (95% CI, 8.1%-12%; n=78) vs 6.3% (95% CI, 4.6%-8.1%; n=49) (P=.005). After adjustment for covariates, this association remained for incidence of injury and failure class of RIFLE-defined AKI (odds ratio, 0.52 [95% CI, 0.37-0.75]; P<.001) and use of RRT (odds ratio, 0.52 [95% CI, 0.33-0.81]; P=.004). There were no differences in hospital mortality, hospital or ICU length of stay, or need for RRT after hospital discharge. Conclusion The implementation of a chloride-restrictive strategy in a tertiary ICU was associated with a significant decrease in the incidence of AKI and use of RRT.
引用
收藏
页码:1566 / 1572
页数:7
相关论文
共 39 条
[1]   Changes in the incidence and outcome for early acute kidney injury in a cohort of Australian intensive care units [J].
Bagshaw, Sean M. ;
George, Carol ;
Bellomo, Rinaldo .
CRITICAL CARE, 2007, 11 (03)
[2]  
Bagshaw SM, 2011, CRIT CARE RESUSC, V13, P201
[3]   Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group [J].
Bellomo, R ;
Ronco, C ;
Kellum, JA ;
Mehta, RL ;
Palevsky, P .
CRITICAL CARE, 2004, 8 (04) :R204-R212
[4]  
Bellomo R, 2009, NEW ENGL J MED, V361, P1627, DOI 10.1056/NEJMoa0902413
[5]   An Official ATS/ERS/ESICM/SCCM/SRLF Statement: Prevention and Management of Acute Renal Failure in the ICU Patient An International Consensus Conference in Intensive Care Medicine [J].
Brochard, Laurent ;
Abroug, Fekri ;
Brenner, Matthew ;
Broccard, Alain F. ;
Danner, Robert L. ;
Ferrer, Miquel ;
Laghi, Franco ;
Magder, Sheldon ;
Papazian, Laurent ;
Pelosi, Paolo ;
Polderman, Kees H. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181 (10) :1128-1155
[6]   INTRARENAL VASOCONSTRICTION DURING HYPERCHLOREMIA - ROLE OF THROMBOXANE [J].
BULLIVANT, EMA ;
WILCOX, CS ;
WELCH, WJ .
AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 256 (01) :F152-F157
[7]   Hospital-wide Code Rates and Mortality Before and After Implementation of a Rapid Response Team [J].
Chan, Paul S. ;
Khalid, Adnan ;
Longmore, Lance S. ;
Berg, Robert A. ;
Kosiborod, Mikhail ;
Spertus, John A. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 300 (21) :2506-2513
[8]   A Randomized, Controlled, Double-Blind Crossover Study on the Effects of 2-L Infusions of 0.9% Saline and Plasma-Lyte® 148 on Renal Blood Flow Velocity and Renal Cortical Tissue Perfusion in Healthy Volunteers [J].
Chowdhury, Abeed H. ;
Cox, Eleanor F. ;
Francis, Susan T. ;
Lobo, Dileep N. .
ANNALS OF SURGERY, 2012, 256 (01) :18-24
[9]   Foreword [J].
Eckardt, Kai-Uwe ;
Kasiske, Bertram L. .
KIDNEY INTERNATIONAL SUPPLEMENTS, 2012, 2 (01) :7-7
[10]  
Finfer S, 2004, NEW ENGL J MED, V350, P2247